Answers are grounded in this paper and cite their sources.
In December 2019, Wuhan City in Hubei Province, China, became the epicenter of a novel coronavirus outbreak, later identified as SARS-CoV-2, the causative agent of COVID-19. Common symptoms of COVID-19 infection include fever, cough, and shortness of breath. This study aimed to determine the percentage distribution of various COVID-19 vaccine types administered at the Gentungan Public Health Center. Employing a non-experimental, descriptive approach, this research analyzed existing data without intervention on test subjects, utilizing a retrospective data collection method. The study population comprised 9,000 individuals, from which a sample of 383 participants was selected. The results indicated the following distribution of vaccine usage: Sinovac was administered to 236 individuals (61.61%), Pfizer to 61 individuals (15.92%), Moderna to 53 individuals (13.83%), and AstraZeneca to 33 individuals (8.61%). Sinovac was the most frequently administered vaccine, likely due to its ample availability and the lack of choice afforded to the public regarding vaccine selection.
No takes yet. Share an insight, caveat, or question.
Basir et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: